Selenium supplementation in patients with peripartum cardiomyopathy: a proof-of-concept trial
We studied the efficacy and safety of selenium supplementation in patients who had peripartum cardiomyopathy (PPCM) and selenium deficiency. We randomly assigned 100 PPCM patients with left ventricular ejection fraction (LVEF)
Gespeichert in:
Veröffentlicht in: | BMC cardiovascular disorders 2020-10, Vol.20 (1), p.457-10, Article 457 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | We studied the efficacy and safety of selenium supplementation in patients who had peripartum cardiomyopathy (PPCM) and selenium deficiency.
We randomly assigned 100 PPCM patients with left ventricular ejection fraction (LVEF) |
---|---|
ISSN: | 1471-2261 1471-2261 |
DOI: | 10.1186/s12872-020-01739-z |